IJNRD Research Journal

WhatsApp
Click Here

WhatsApp editor@ijnrd.org
IJNRD
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.76

Issue per Year : 12

Volume Published : 9

Issue Published : 95

Article Submitted :

Article Published :

Total Authors :

Total Reviewer :

Total Countries :

Indexing Partner

Join RMS/Earn 300

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: Pharmacological perspective to mitigate the COVID-19 management in the Alzheimer’s Disease and Related Dementia: An update
Authors Name: Subhasish Sahoo , Diptirani Rath
Download E-Certificate: Download
Author Reg. ID:
IJNRD_180558
Published Paper Id: IJNRD2203002
Published In: Volume 7 Issue 3, March-2022
DOI:
Abstract: Background COVID-19 was found in late 2019 which causes severe respiratory illness. Cognitive impairment patients who are suffering from Alzheimer’s Disease and Related Dementias (ADRD) are having a higher risk of COVID infection and other pulmonary diseases leading to a high mortality rate. A risk factor is the ‘age’ that forms a link between Alzheimer’s and the morbidity related to COVID 19. This perspective encloses the measures which may help to mitigate the management of COVID-19 in Alzheimer’s Disease and Related Dementias (ADRD). The article updates primarily on prevalence, incidence, associated risk factors, supervision, and care for patients suffering from ADRD which can help to decrease the burden on the patients suffering from ADRD. Methods This article was reviewed referring to websites like Scopus, Google Scholar, ScienceDirect, PubMed, MedKnow Publications, NCBI.NLM.NIH, EBSCO, Web of Science, etc. Results and Discussion It was illustrated by various cases of COVID 19 that people with elderly i.e., above 70 years were at high risk of mortality due to weaker immune system, synaptic loss, and impaired cognition. Mortality due to pneumonia is twice more prevalent in dementia patients than in the without dementia. Smoking is another risk factor for AD in elderly persons. According to the previous cases reported, it was found that people who were taking high consumption of fish, omega-3-polyunsaturated fatty acid diet linked to lessen the chances of AD and dementia-like symptoms. Patients with AD and related dementia should be encouraged for virtual meeting/ e-consultation/ telemedicine/ online mental health programs instead of clinical visits. Vaccination would greatly assist geriatric people during the COVID-19 pandemic which may help them to overcome the infection.
Keywords: COVID-19, Alzheimer’s disease, Cognitive impairment, pulmonary diseases, risk factors, Geriatric vaccination.
Cite Article: "Pharmacological perspective to mitigate the COVID-19 management in the Alzheimer’s Disease and Related Dementia: An update", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.7, Issue 3, page no.27-31, March-2022, Available :http://www.ijnrd.org/papers/IJNRD2203002.pdf
Downloads: 000118757
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID:IJNRD2203002
Registration ID: 180558
Published In: Volume 7 Issue 3, March-2022
DOI (Digital Object Identifier):
Page No: 27-31
Country: Bhubaneswar, Odisha, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2203002
Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2203002
Share Article:
Share

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijnrd.org
Semantic Scholar Microsaoft Academic ORCID Zenodo
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX PUBLON
DRJI SSRN Scribd DocStoc

ISSN Details

ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to Get DOI? DOI

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Join RMS/Earn 300

IJNRD